CN1211448A - 双酵胶囊 - Google Patents

双酵胶囊 Download PDF

Info

Publication number
CN1211448A
CN1211448A CN 97108656 CN97108656A CN1211448A CN 1211448 A CN1211448 A CN 1211448A CN 97108656 CN97108656 CN 97108656 CN 97108656 A CN97108656 A CN 97108656A CN 1211448 A CN1211448 A CN 1211448A
Authority
CN
China
Prior art keywords
capsule
acid
keratin
amylase
starch
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 97108656
Other languages
English (en)
Inventor
刘伟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 97108656 priority Critical patent/CN1211448A/zh
Publication of CN1211448A publication Critical patent/CN1211448A/zh
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

本发明给出了一种医疗保健用药双酵胶囊。它选用双歧杆菌粉、酵母菌粉、解脂酶、转化糖酶、淀粉酶、山楂酸、柠檬酸、VB、磷脂、角蛋白、淀粉为配料,将其混合均匀,装入肠溶性胶囊而获得,它不仅能直接将药粉送入人体肠中发挥其治疗保健作用,避免因服用有双岐菌液而引起的不必要感染,而且对于因脾胃素虑而引起的胃不纳食、腹胀、腹痛、身倦泛力和因乱用抗生素所引起的便秘、食欲不振病症疗效明显。

Description

双酵胶囊
本发明涉及一种医疗保健用药尤其是一种以双歧杆菌与酵母菌为主要成分的双酵胶囊。
在众多的微生物中,寄生在人和动物肠道内的厌氧菌双岐杆菌是世界上公认的对人类有保健医疗作用的细菌,它参与建造和增强人体免疫力,参与人体对营养物质的消化和吸收,参与人体抗衰老过程,参与癌症防治,清除体内毒素而保护肝功能,治疗菌群失调症,还有治疗精神病,防治放射性疾病和水土不服及抗过敏等功效在临床上均有成功的报导。由于双岐杆菌寄生于大肠内才有益于人类,如果该菌侵入人体其它部位时,则可弓起感染,如腹膜炎、胆囊炎、膀胱炎等症。而现行市场上流通的此类制剂,多以口服液剂型应市,患者服用后菌液经口腔、食道、胃才进入肠道,它可引起服用者副反应,如腹泻、泛酸和上腹不适等症。如菌液不慎侵入人体其它器官,就可弓起感染,不但未达到治病的目的而适得其反。
本发明的目的在于提供一种能治疗脾胃索虚而弓起的胃不纳食、腹胀、腹痛、身倦泛力和因乱用抗生素所弓起的便秘、食欲不振症并能避免因服用双岐菌液不慎而引起的不必要感染的医疗保健药品双酵胶囊。
本发明是这样实现的,它选用双歧杆菌粉、酵母菌粉、解脂酶、转化糖酶、淀粉酶、山楂酸、柠橡酸、VB、磷脂、角蛋白、淀粉为配料,将其混合均匀,装入肠溶性胶囊之中而获得,其各选配料的重量比例是双歧杆菌粉∶酵母菌粉∶解脂酶∶转化糖酶∶淀粉酶∶山楂酸∶柠檬酸∶VB∶磷脂∶角蛋白∶淀粉=30∶20∶3∶3∶4∶2∶2∶2∶1∶3∶30。
本发明的优点在于它采用了肠溶性胶囊能将双岐菌粉、酵母菌粉等直接送入人体肠中发挥其治疗保健作用,避免了因服用有双岐菌液而引起不必要感染。而对于因脾胃素虚而引起的胃不纳食、腹胀、腹痛、身倦泛力和对因乱用抗生素所引起的便秘、食欲不振病症疗效明显。同时对肝病患者还可作为辅助用药。
下面以实旋例对本发明进一步说明:
本发明是选用双歧杆菌粉、酵母菌粉、解脂酶、转化糖酶、淀粉酶、山楂酸、柠橡酸、VB、磷脂、角蛋白、淀粉为配料,将其混合均匀,装入肠溶性胶囊之中而获得,其各选配料的重量比例是双歧杆菌粉∶酵母菌粉∶解脂酶∶转化糖酶∶淀粉酶∶山楂酸∶柠檬酸∶VB∶磷脂∶角蛋白∶淀粉=30∶20∶3∶3∶4∶2∶2∶2∶1∶3∶30。其所述的双歧菌粉是采用现行技术的冷冻干燥法或真空干燥法所获得,其余所有配料均采用现行市售的药用粉料,所使用的肠溶性胶囊为现市售的胶囊,每个胶囊内装0.35g,每天服用2-3次,每次服用2-4粒,小儿酌情减用或遵医嘱。

Claims (1)

  1. 一种用于医疗保健用药双酵胶囊,其特征在于它选用双歧杆菌粉、酵母菌粉、解脂酶、转化糖酶、淀粉酶、山楂酸、柠檬酸、VB、磷脂、角蛋白、淀粉为配料,将其混合均匀,装入肠溶性胶囊之中而获得,其各选配料的重量比例是双歧杆菌粉∶酵母菌粉∶解脂酶∶转化糖酶∶淀粉酶∶山楂酸∶柠檬酸∶VB∶磷脂∶角蛋白∶淀粉=30∶20∶3∶3∶4∶2∶2∶2∶1∶3∶30。
CN 97108656 1997-09-18 1997-09-18 双酵胶囊 Pending CN1211448A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 97108656 CN1211448A (zh) 1997-09-18 1997-09-18 双酵胶囊

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 97108656 CN1211448A (zh) 1997-09-18 1997-09-18 双酵胶囊

Publications (1)

Publication Number Publication Date
CN1211448A true CN1211448A (zh) 1999-03-24

Family

ID=5170593

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 97108656 Pending CN1211448A (zh) 1997-09-18 1997-09-18 双酵胶囊

Country Status (1)

Country Link
CN (1) CN1211448A (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1123695A3 (en) * 2000-01-28 2001-09-26 Unilever N.V. Oral composition comprising capsules containing keratin

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1123695A3 (en) * 2000-01-28 2001-09-26 Unilever N.V. Oral composition comprising capsules containing keratin

Similar Documents

Publication Publication Date Title
Chow Probiotics and prebiotics: a brief overview
ES2610908T3 (es) Cepas de bifidobacterium bifidum para su aplicación en enfermedades gastrointestinales
Oyetayo et al. Potential of probiotics as biotherapeutic agents targeting the innate immune system
ES2324532T3 (es) Bacteria probiotica: lactobacillus fermentum.
ES2216611T3 (es) Preparacion que contiene oligosacaridos y probioticos.
US8722035B2 (en) Formulations including digestive enzymes, polysorbate-based surfactants and probiotics
JP4456649B2 (ja) ペットフード用新規プロバイオチックス
ES2640212T3 (es) Uso de bifidobacterias pro bióticas administradas por vía oral para obtener beneficios de belleza en seres humanos
EP1596872B1 (en) Compositions and methods for restoring bacterial flora
CN110051003A (zh) 一种复合益生菌组合物及其应用
US20030147857A1 (en) Probiotic/prebiotic composition and delivery method
CN109451727A (zh) 益生菌和消化酶的组合物及其制备和使用方法
CN106539089A (zh) 一种复合益生元及其应用
CN104161263B (zh) 儿童全营养配方食品
CA2429117C (en) Remedy for diabetes mellitus
CN102106925B (zh) 枸杞多糖双歧杆菌合生元结肠靶向微生态调节剂
JP2011116666A (ja) 乳酸菌発酵ローヤルゼリーを含有する抗ストレス剤及びその製造方法
CN107889997A (zh) 一种益生菌冻干粉固体饮料
EP0446069B1 (en) Treatment of clostridium difficile diarrhoea and pseudomembranous colitis
Kirk Significant drug-nutrient interactions.
JPH05506228A (ja) 止痢薬組成物及び方法
CN1211448A (zh) 双酵胶囊
CN106666738A (zh) 一种用于改善人体代谢紊乱状态的组合物及其制备方法
JP2022508702A (ja) 消化器系及び免疫系の障害を治療する為のヒト用栄養補助食品及び方法
CN103637180A (zh) 一种眼睛疾病患者食用的特殊膳食

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication